Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Entrepreneurs stay the course: 92% would choose this path again
-
Perspective Therapeutics Presents Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET at the ESMO Congress 2025
-
Niu Technologies to Report Third Quarter 2025 Financial Results on November 17, 2025
-
ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors
-
Sobi Q3 2025 report: Accelerated growth and portfolio momentum
-
GiftCardMall.org Simplifies Gift Card Management with Instant Balance Checking and Easy Activation
-
Prepayments, Realkredit Danmark A/S
-
CoinEx Reinforces Transparency with Updated Proof of Reserve – October 2025
-
Alm. Brand A/S – Weekly report on share buybacks
-
Net Asset Value(s)
-
Share buyback programme - week 42
-
Preliminary data on early redemptions (prepayments)
-
ESMO releases first-ever guidance for safe use of AI Language Models in cancer care
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
What Does Your Heaven Look Like by Davida Coleman on Display at Explora Books Booth
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
Monster Army's Chris Setinas Takes Third Place at the 2025 Tampa Am Street Skateboarding Competition
-
Columbus – Weekly report on share buyback
-
CoinLander Launches RWA Platform, Unlocking Stable Returns from Tokenized Real Estate Mortgages
-
Explora Books to Showcase A New Beginning at Frankfurter Buchmesse 2025
-
Pollo AI Launches Revolutionary AI Video Editor to Transform Videos with Prompt
-
Join FiveCrypto and complete the AI Training Model to Get 0.1 ETH Reward
-
Day 2 of 2025 Sustainable Global Leaders Conference: Nobel Laureate Shares AI Insights, Major ESG Achievements Announced
-
Rediscovering the Wisdom of Human Nature by Chet Shupe Exhibited at Frankfurter Buchmesse 2025
-
Hilda Sotos The Hidden Truth Showcased at Explora Books Hall 51 D59
-
Saint Kitts and Nevis Introduces Blockchain-Verified Certification for Due Diligence Reports
-
Lake Victoria Gold Announces Closing of Non-Brokered Concurrent Private Placement of $2 Million
-
NORBIT - Awarded NOK 120 million order
-
Aspocomp will publish its January-September Interim Report 2025 on Thursday, October 30, 2025
-
Municipality Finance issues SEK 1 billion tap under its MTN programme
-
Municipality Finance issues a EUR 50 million tap under its MTN programme
-
Stay warm all winter with heater maintenance tips from the Paso Robles HVAC repair service
-
Paso Robles broker leads in California vineyard and estate sales
-
Bright smiles at any age--strategies for seniors from the Paso Robles dentist
-
Outfit7: Teeth and Treats Take Over My Talking Tom Friends in Halloween Update
-
AP Pension selects Cognizant for BPO and RPA-services as part of multi-year transformation
-
Caranx Medical (CarvOlix group) to Showcase Latest Updates at the 37th Annual Transcatheter Cardiovascular Therapeutics® Conference (TCT)
-
Valeo Foods Group Recognised for Sustainability Leadership with EcoVadis Platinum Medal
-
Empowered with Meg Ryan and Buckhorn Therapeutic Care Explore the Resilience of Children in Foster Care
-
Medela AG Introduces the New Motion InBra™ Wearable Breast Pump – Where Dependable Performance Meets Everyday Comfort
-
JSBC Unveils "Chinese Wisdom" Book Series for Global Audiences
-
PRESS RELEASE: CMB.TECH NV announces fixed income investor meetings
-
PRESS RELEASE: CMB.TECH trading update
-
ESMO Congress 2025 Presidential Symposium Oral Presentation | Disitamab Vedotin Achieves Major Breakthrough as First-Line Treatment for Urothelial Carcinoma
-
Immunotherapy After Surgery Shows Promise in Treating Rare, Aggressive Skin Cancer
-
EXEED Co-Creation Workshop: Texxeract Technology Premieres, Three New Models Debut with the New Family Design Language
-
Debtor distribution data (CK92) - Totalkredit A/S
-
Debtor distribution data (CK92) - Nykredit Realkredit A/S
-
Exelixis Announces Detailed Results from Phase 3 STELLAR-303 Pivotal Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibitor in Metastatic Colorectal Cancer Presented at ESMO
-
IO Biotech Presents Phase 3 Results for Cylembio® plus KEYTRUDA® (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
